SHPMF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
8.5B
Intraday BUY SELL Signals
SHPMY
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
8.5B
Intraday BUY SELL Signals
Interact to see
Advertisement

SHPMF vs SHPMY

Header iconSHPMF vs SHPMY Comparison
Open Charts SHPMF vs SHPMYBanner chart's image
Shanghai Pharmaceuticals Holdings
PriceLoading...
Change-$0.00 (-0.00%)
Volume$4.6K
Capitalization8.5B
Shanghai Pharmaceuticals Holdings
PriceLoading...
Change-$0.00 (-0.00%)
Volume$161
Capitalization8.5B
SHPMF vs SHPMY Comparison Chart in %
SHPMF
Daily Signal:
Gain/Loss:
SHPMY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SHPMF vs. SHPMY commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHPMF is a Hold and SHPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (SHPMF: $1.53 vs. SHPMY: $8.23)
Brand notoriety: SHPMF and SHPMY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: SHPMF: 100% vs. SHPMY: 103%
Market capitalization -- SHPMF: $8.5B vs. SHPMY: $8.5B
SHPMF [@Medical Distributors] is valued at $8.5B. SHPMY’s [@Medical Distributors] market capitalization is $8.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $100.49B to $0. The average market capitalization across the [@Medical Distributors] industry is $11.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SHPMF’s FA Score shows that 0 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).

  • SHPMF’s FA Score: 0 green, 5 red.
  • SHPMY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHPMY is a better buy in the long-term than SHPMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHPMF’s TA Score shows that 0 TA indicator(s) are bullish while SHPMY’s TA Score has 1 bullish TA indicator(s).

  • SHPMF’s TA Score: 0 bullish, 1 bearish.
  • SHPMY’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, SHPMF is a better buy in the short-term than SHPMY.

Price Growth

SHPMF (@Medical Distributors) experienced а 0.00% price change this week, while SHPMY (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.57%. For the same industry, the average monthly price growth was +3.81%, and the average quarterly price growth was +4.45%.

Industries' Descriptions

@Medical Distributors (+2.57% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMF($8.5B) and SHPMY($8.5B) have the same market capitalization . SHPMY has higher P/E ratio than SHPMF: SHPMY (7.61) vs SHPMF (7.12). SHPMY YTD gains are higher at: 1.486 vs. SHPMF (-6.707). SHPMF (14.2B) and SHPMY (14.2B) have comparable annual earnings (EBITDA) . SHPMF (47.5B) and SHPMY (47.5B) have equal amount of cash in the bank . SHPMF (55.2B) and SHPMY (55.2B) have identical debt. SHPMF (277B) and SHPMY (277B) have equivalent revenues.
SHPMFSHPMYSHPMF / SHPMY
Capitalization8.5B8.5B100%
EBITDA14.2B14.2B100%
Gain YTD-6.7071.486-451%
P/E Ratio7.127.6194%
Revenue277B277B100%
Total Cash47.5B47.5B100%
Total Debt55.2B55.2B100%
FUNDAMENTALS RATINGS
SHPMF vs SHPMY: Fundamental Ratings
SHPMF
SHPMY
OUTLOOK RATING
1..100
4746
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
7676
PRICE GROWTH RATING
1..100
7251
P/E GROWTH RATING
1..100
8482
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHPMY's Valuation (76) in the null industry is in the same range as SHPMF (79). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.

SHPMY's Profit vs Risk Rating (74) in the null industry is in the same range as SHPMF (100). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.

SHPMY's SMR Rating (76) in the null industry is in the same range as SHPMF (76). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.

SHPMY's Price Growth Rating (51) in the null industry is in the same range as SHPMF (72). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.

SHPMY's P/E Growth Rating (82) in the null industry is in the same range as SHPMF (84). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SHPMFSHPMY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
Bullish Trend 7 days ago
56%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
30%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
SHPMF
Daily Signal:
Gain/Loss:
SHPMY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WOMN41.350.36
+0.87%
Impact Shares Women’s Empowerment ETF
RWX27.960.09
+0.32%
SPDR® Dow Jones® International RelEstETF
QMNV23.360.06
+0.24%
FT Vest Nasdaq-100® Mod Buffr ETF – Nov
USSH50.890.06
+0.12%
WisdomTree 1-3 Year Laddered Trsy ETF
FSCO6.02-0.08
-1.31%
FS Credit Opportunities Corp

SHPMF and

Correlation & Price change

A.I.dvisor tells us that SHPMF and ARRJF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMF and ARRJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMF
1D Price
Change %
SHPMF100%
N/A
ARRJF - SHPMF
8%
Poorly correlated
N/A
SHPMY - SHPMF
7%
Poorly correlated
N/A
ZYXI - SHPMF
5%
Poorly correlated
-0.85%
COSM - SHPMF
2%
Poorly correlated
-10.81%
MAHLY - SHPMF
2%
Poorly correlated
N/A
More

SHPMY and

Correlation & Price change

A.I.dvisor tells us that SHPMY and NSVGF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
N/A
NSVGF - SHPMY
14%
Poorly correlated
N/A
COSM - SHPMY
12%
Poorly correlated
-10.81%
SHTDF - SHPMY
12%
Poorly correlated
N/A
ZYXI - SHPMY
7%
Poorly correlated
-0.85%
SHPMF - SHPMY
7%
Poorly correlated
N/A
More